1. Food and Drug Administration. FDA grants traditional approval to tarlatamab-dlle for extensive-stage small-cell lung cancer. FDA. November 19, 2025. Accessed November 19, 2025.

The FDA has granted an accelerated approval to sevabertinib (Hyrnuo) for the treatment of adult patients with previously treated locally advanced or metastatic, nonsquamous non–small cell lung cancer ...

As Saudi Arabia’s ambitious Vision 2030 program transforms the nation into a nexus of cultural riches and scientific ...

The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...

In recent weeks, at least 23 infants in the U.S. have been infected with botulism in an outbreak linked to ByHeart powdered ...

The FDA has approved new safety warnings and a revised indication for Elevidys following multiple reports of fatal acute liver failure in non-ambulatory patients with DMD.

Novo Nordisk is expected to announce soon whether its blockbuster GLP-1 drug semaglutide can help slow Alzheimer’s disease ...

American inspections of foreign food facilities -- which produce everything from crawfish to cookies for the U.S. market -- ...

Food safety technology innovations are accelerating as rising contamination risks and stricter regulations expose the limits ...

A second lawsuit has been filed against baby formula company ByHeart by a food safety law firm following an outbreak of ...

While they can be bought online for between $300 to $600, the products have not been extensively trialed or studied in humans ...

Drug candidates don't usually move among Big Pharma, but these five biotechs helped facilitate such hand-offs, scooping up ...